FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1224 November 2, 1995 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In their study of patients with chronic post-transfusion hepatitis C who were seen at a referral center, Tong et al. (June 1 issue)¹ concluded that the disease was progressive and, in some patients, led to death from liver failure or hepatocellular carcinoma. These findings are in contrast to those of Seeff et al.,² who reported no increase in mortality from transfusion-associated non-A, non-B hepatitis.² In the retrospective study by Tong et al., any patient who had received a blood transfusion and in whom chronic hepatitis C developed was considered to have post-transfusion hepatitis C virus (HCV) infection. . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kammer, A. R., van der Burg, S. H., Grabscheid, B., Hunziker, I. P., Kwappenberg, K. M.C., Reichen, J., Melief, C. J.M., Cerny, A. (1999). Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition. J. Exp. Med. 190: 169-176 [Abstract] [Full Text]